SPC438
Deucravacitinib eða lyfjafræðilega viðunandi salt þar af
:
Veitt:
23.8.2023:
15.9.2023:
15.7.2025
:
26.3.2038:
SOTYKTU
23.8.2023
15.9.2023
15.7.2025
26.3.2038
:
EU/1/23/1718/001-008:
21.4.2023
:
EU/1/23/1718:
24.3.2023
:
Bristol-Myers Squibb Company:
Route 206 and Province Line Road, Princeton US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113 Reykjavík